C, Y., FZ, Z., EV, C., LLH, L., E, S., JS, W., . . . N, K. (2021). The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study. Dove Medical Press.
Cita Chicago Style (17a ed.)C, Yatawara, Zailan FZ, Chua EV, Lim LLH, Silva E, Wang JS, Ng A, Ng KP, y Kandiah N. The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study. Dove Medical Press, 2021.
Cita MLA (8a ed.)C, Yatawara, et al. The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study. Dove Medical Press, 2021.